AzTrials
AzTrials

Adhesive CapsulitisNCT07724613

Comparative Effects of Gongs and Maitland Mobilization in Patients With Adhesive Capsulitis

A study testing Group A: Gong's Mobilization and Maitland Mobilization in people with Adhesive Capsulitis, run by Riphah International University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Adhesive capsulitis is a common musculoskeletal disorder characterized by shoulder pain, restricted range of motion (ROM), and functional disability, leading to limitations in daily activities and reduced quality of life. Read more about this study

Who is it for?
Ages 40 to 65 years
Conditions the study is for
Adhesive Capsulitis
What is being tested?
Group A: Gong's Mobilization and Maitland Mobilization
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
52 participants
Where
No sites listed yet
Study dates
Jul 2026to 30 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged between 40-65 years.
  • Both male and female genders
  • Stage II and III frozen shoulder
  • Positive Apley's Scratch test
  • Pain rating 3 to 7 on NPRS for at least 3 months
  • Frozen shoulder with at least 25% restricted ROM

Who cannot join

  • Mental disorders
  • Arthritic shoulder
  • Rotator cuff disease
  • Post-traumatic stiff shoulder
  • Post-CABG shoulder-hand syndrome
  • Post-stroke frozen shoulder
Show all 9Show fewer
  • Bilateral frozen shoulder
  • Neurological disorders
  • Frozen Shoulder secondary to Brachial Plexus Injury, Parkinsonism, Ankylosis, Infection, or Arthroplasty

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Comparative Effects of Gongs and Maitland Mobilization on Pain, Range of Motion, and Functional Disability in Patients With Adhesive Capsulitis

Adhesive capsulitis is a common musculoskeletal disorder characterized by shoulder pain, restricted range of motion (ROM), and functional disability, leading to limitations in daily activities and reduced quality of life. Manual therapy techniques, including Gong's Mobilization and Maitland Mobilization, are widely used in physiotherapy management; however, evidence comparing their effectiveness remains limited.

Read the detailed description

The study aim to compare the effects of Gong's Mobilization and Maitland Mobilization on pain, shoulder range of motion, and functional disability in patients with adhesive capsulitis. A randomized clinical trial will be conducted on 60 participants diagnosed with stage II and III adhesive capsulitis. Participants will be randomly allocated into two groups: Gong's Mobilization and Maitland Mobilization. Both groups also received conventional physiotherapy, including hot pack application, stretching, isometric exercises, and a home exercise program. Outcome measures includes the Numeric Pain Rating Scale (NPRS), Shoulder Pain and Disability Index (SPADI), and shoulder ROM assessed using a goniometer. Assessments will be performed at baseline, Week 3, and Week 6. Data were analyzed using Mann-Whitney U and Friedman tests with a significance level of p ≤ 0.05.

Being tested
Group A: Gong's Mobilization, Maitland Mobilization
Keywords
Adhesive capsulitis, frozen shoulder, Gong's mobilization, Maitland mobilization, pain, range of motion, functional disability, physiotherapy.
Medical subject headings
Bursitis, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group A: Gong's MobilizationOther

    According to the criteria described by Gong et al., the patient was positioned in supine lying while the affected arm was placed upward to maintain the humerus in an upright position, with the elbow flexed to 90 degrees and the shoulder abducted to 90 degrees[A31.1]. The therapist then held the patient's hand and applied anterior-to-posterior pressure to the humerus while maintaining the elbow at a 90-degree angle. Subsequently, the therapist gently applied pressure to the articular capsule of the shoulder joint while elevating the patient's torso. The articular capsule was gently mobilized for 10-15 seconds followed by a 5-second release period. The therapist used one hand to perform medial rotation of the shoulder while stabilizing the elbow. This technique was performed for five sessions per week for four weeks, with 10-15 repetitions during each session

  • Maitland MobilizationOther

    Maitland mobilization using posterior glide technique was administered with the patient in a supine position. The therapist grasped the head of the humerus with one hand to perform the movements and stabilized the clavicular region with the other hand. The therapist remained in a standing position while applying the glides. To further stabilize the scapula and prevent scapular protraction, a towel was placed underneath the scapula, allowing smoother scapular glides[A.

Study groups in NCT07724613
Study groupRoleWhat they receive
Gong's MobilizationExperimentalGroup A will receive Gong's Mobilization for adhesive capsulitis.
Receives: Other: Group A: Gong's Mobilization
Maitland MobilizationActive comparatorGroup B will receive Maitland Mobilization for adhesive capsulitis.
Receives: Other: Maitland Mobilization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Numeric Pain Rating Scale (NPRS)

    The Numeric Pain Rating Scale (NPRS) was a widely used tool designed to assess pain intensity in both clinical and research settings. It consisted of an 11-point scale ranging from 0 to 10, where 0 represented "no pain" and 10 indicated the "worst imaginable pain."

    Measured: upto 6 weeks

Secondary outcomes (2)
  1. Goniometer

    The goniometer was a widely used instrument in clinical and rehabilitation settings to measure joint angles and assess the range of motion (ROM).

    Measured: upto 6 weeks

  2. Shoulder Pain and Disability Index (SPADI)

    The Shoulder Pain and Disability Index (SPADI) was a self-administered questionnaire designed to evaluate pain and functional impairment related to shoulder disorders. It consisted of 13 items divided into pain and disability subscales and was often used in both clinical practice and research.

    Measured: upto 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2026
  2. Study startJul 2026 (estimated)
  3. Primary completion30 Nov 2026 (estimated)
  4. Study completion30 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
52 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07724613
Sponsor's protocol ID
REC/RCR & AHS/25/0139
Status last verified
Jul 2026
First submitted
21 Jul 2026
Last updated
24 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Choi JM, Cho EY, Lee BH. Effects of Dynamic Stretching Combined with Manual Therapy on Pain, ROM, Function, and Quality of Life of Adhesive Capsulitis. Healthcare (Basel). 2023 Dec 24;12(1):45. doi: 10.3390/healthcare12010045.

    PubMed 38200951
  • Xia WZ, Cortes RE, Chin KF, Cobiella C, Lambert S. "Idiopathic" adhesive capsulitis is caused by reactivation of latent neurotrophic virus involving peripheral nerves around the shoulder capsule: A hypothesis. Medical Hypotheses. 2025;197:111604.

  • Nakandala P, Nanayakkara I, Wadugodapitiya S, Gawarammana I. The efficacy of physiotherapy interventions in the treatment of adhesive capsulitis: A systematic review. J Back Musculoskelet Rehabil. 2021;34(2):195-205. doi: 10.3233/BMR-200186.

    PubMed 33185587
  • Sarasua SM, Floyd S, Bridges WC, Pill SG. The epidemiology and etiology of adhesive capsulitis in the U.S. Medicare population. BMC Musculoskelet Disord. 2021 Sep 27;22(1):828. doi: 10.1186/s12891-021-04704-9.

    PubMed 34579697
  • Fernandes MR. Adhesive capsulitis: current concepts. Musculoskelet Surg. 2026 Mar;110(1):1-10. doi: 10.1007/s12306-025-00897-7. Epub 2025 Mar 17.

    PubMed 40095380
  • Kulm S, Langhans MT, Shen TS, Kolin DA, Elemento O, Rodeo SA. Genome-Wide Association Study of Adhesive Capsulitis Suggests Significant Genetic Risk Factors. J Bone Joint Surg Am. 2022 Nov 2;104(21):1869-1876. doi: 10.2106/JBJS.21.01407. Epub 2022 Nov 2.

    PubMed 36223477
  • Jacob L, Gyasi RM, Koyanagi A, Haro JM, Smith L, Kostev K. Prevalence of and Risk Factors for Adhesive Capsulitis of the Shoulder in Older Adults from Germany. J Clin Med. 2023 Jan 14;12(2):669. doi: 10.3390/jcm12020669.

    PubMed 36675599
  • Do JG, Hwang JT, Yoon KJ, Lee YT. Correlation of Ultrasound Findings With Clinical Stages and Impairment in Adhesive Capsulitis of the Shoulder. Orthop J Sports Med. 2021 May 10;9(5):23259671211003675. doi: 10.1177/23259671211003675. eCollection 2021 May.

    PubMed 33997079
  • Leafblad N, Mizels J, Tashjian R, Chalmers P. Adhesive Capsulitis. Phys Med Rehabil Clin N Am. 2023 May;34(2):453-468. doi: 10.1016/j.pmr.2022.12.009. Epub 2023 Feb 28.

    PubMed 37003663

Questions about this trial

What is this clinical trial studying?

A study testing Group A: Gong's Mobilization and Maitland Mobilization in people with Adhesive Capsulitis, run by Riphah International University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sumrod Akram (03324806143, samrood.akram@riphah.edu.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Numeric Pain Rating Scale (NPRS) (time frame: upto 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07724613, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in